Aromatase inhibitors eliminate estrogen, which is critical to bone mineral density in women. Without estrogen signaling, osteoclast activity dramatically accelerates, depleting calcium and collagen from bone matrix. The rate of bone loss exceeds that of menopause alone.
Eastell et al. (NEJM, 2008) — aromatase inhibitors cause 2–3% bone loss per year (vs. 1–2% in menopause). Sestak et al. (Lancet Oncol, 2015) — 10% of AI patients develop clinical osteoporosis within 5 years without supplementation.
Accelerated bone loss, osteoporosis, increased fracture risk (hip, vertebral, wrist), joint pain
DEXA scan at baseline and annually. Vitamin D3 to 50–80 ng/mL (typically 2,000–5,000 IU). Calcium 1,000–1,200mg from food + supplement. Weight-bearing exercise mandatory. Discuss bisphosphonate co-therapy with oncologist if DEXA shows significant loss.
View on Fullscript: Thorne Vitamin D/K2 LiquidDiscuss with your physician before adjusting supplementation. This is educational content, not medical advice.
Cancer and its treatment create substantial oxidative stress. Tamoxifen specifically has been shown to impair mitochondrial function and reduce CoQ10 in breast tissue and systemically. Anthracycline chemotherapy (often co-administered) is a well-known cardiotoxin that drastically reduces CoQ10.
Conklin (Cancer Biother Radiopharm, 2004) — CoQ10 depletion in breast cancer patients, particularly with concurrent anthracycline chemotherapy. Tamoxifen impairs mitochondrial membrane potential.
Fatigue (the primary complaint with AIs), cardiac side effects risk, muscle weakness
Ubiquinol 200–300mg daily. Especially critical if patient has received or is receiving anthracycline chemotherapy (doxorubicin). Discuss with oncologist.
View on Fullscript: Life Extension Super Ubiquinol CoQ10Discuss with your physician before adjusting supplementation. This is educational content, not medical advice.
Tamoxifen and aromatase inhibitors cause significant musculoskeletal side effects (joint pain, muscle aches in 30–50% of patients). Magnesium deficiency amplifies musculoskeletal pain and inflammation. Estrogen normally supports magnesium retention; its elimination increases magnesium losses.
Estrogen promotes renal magnesium conservation — AI-induced estrogen suppression increases urinary magnesium excretion. Clinical magnesium supplementation trials show reduced musculoskeletal side effects in AI patients.
Joint pain (arthralgia — most common AI side effect), muscle cramps, fatigue, insomnia
Magnesium glycinate 300–400mg daily. This is one of the most impactful interventions for AI-induced arthralgia — the #1 reason women discontinue therapy.
View on Fullscript: Thorne Magnesium BisglycinateDiscuss with your physician before adjusting supplementation. This is educational content, not medical advice.
Taking Aromatase Inhibitors / Tamoxifen? Build Your Replenishment Stack.
Our clinical intake tool accounts for your medications, health goals, and risk factors — and outputs a personalized supplement protocol rated against published clinical trials.
Open the Full Tool Suite